Thought Leadership Drug Discovery Targets & Screening |

Executive Interview with Peter Sullivan, MyxoTech

On-Demand
July 11, 2025
|
00:00 UK Time
|
Event lasts 17m
Peter Sullivan

Peter Sullivan

Chief Executive Officer

MyxoTech

Format: 17 minute interview

Related posts
Interview with Paul Workman

Interview with Paul Workman

Paul Workman Institute of Cancer Research
Drug Discovery
Feb, 2026
Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Rick Ewing Rapafusyn Pharmaceuticals
Zoran Rankovic St. Jude Children’s Research Hospital
Kyle Eastman Halda Therpeutics
Danette Daniels Foghorn Therapeutics
Drug Discovery
Jan, 2026
Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Stefan Schiesser AstraZeneca
Drug Discovery
Nov, 2025
Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms

Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms

Aline Miller University of Manchester
Vasiliki Kalodimou European University-Cyprus – Frankfurt Branch
Maryna Panamarova Wellcome Sanger Institute
Andy Wiranata Wijaya Nestlé
Drug Discovery
Nov, 2025
Unlocking the Brain- Innovations in CNS Drug Discovery and Neurodegenerative Treatment

Unlocking the Brain- Innovations in CNS Drug Discovery and Neurodegenerative Treatment

Emma Mead Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford
S Moein Moghimi School of Pharmacy, Newcastle University, UK
Shadi Farhangrazi S. M. Discovery Group (SMDG)
Ralph Minter Alchemab
Drug Discovery
Sep, 2025
Upcoming events
02
Sep
Innovative Screening Techniques

Online

This technology showcase highlights cutting-edge methods for high-content data capture and complex assay workflows. Experience live demonstrations and engage with experts on overcoming challenges and leveraging advanced screening to accelerate your discovery process.

12
Oct
Drug Discovery US 2026

In-Person

Join top scientific experts at our annual Drug Discovery programme—where innovation meets impact. Dive into breakthrough strategies and cutting-edge advances in novel modalities, including PROTACs and molecular glues, and explore how AI and computational tools are reshaping early-stage discovery. Gain real-world insights from new case studies and stay ahead of the curve in accelerating the journey from target to candidate.

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.